Barclay Phillips
Directeur/Membre du Conseil chez IMMUNIC, INC.
Fortune : - $ au 30/04/2024
Postes actifs de Barclay Phillips
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| IMMUNIC, INC. | Directeur/Membre du Conseil | 19/11/2019 | - |
| Independent Dir/Board Member | 19/11/2019 | - | |
Immunic AG
 Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Directeur/Membre du Conseil | - | - |
Ribometrix, Inc.
 Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | Directeur des opérations | 04/08/2020 | - |
| Directeur Financier/CFO | 04/08/2020 | - |
Historique de carrière de Barclay Phillips
Anciens postes connus de Barclay Phillips
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| G1 THERAPEUTICS, INC. | Directeur Financier/CFO | 08/11/2017 | 10/05/2019 |
| NOVAVAX, INC. | Directeur Financier/CFO | 24/06/2013 | 10/11/2017 |
| Treasurer | 24/06/2013 | 10/11/2017 | |
Amgen Rockville, Inc.
 Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Directeur Financier/CFO | 01/12/2000 | 29/07/2009 |
Vector Asset Management, Inc.
 Vector Asset Management, Inc. Investment ManagersFinance Vector Asset Management, Inc. is a venture capital firm based in Deerfield, Illinois | Directeur en chef des Investissements | 01/11/1999 | 30/09/2008 |
| Membre du Comité d'Investissement | 01/11/1999 | 30/09/2008 | |
| Analyste en capital-investissement | 01/11/1999 | 30/09/2008 | |
| Private Equity Investor | 01/11/1999 | 30/09/2008 | |
| Corporate Officer/Principal | 01/11/1999 | 30/09/2008 | |
Vector Fund Management LP
 Vector Fund Management LP Investment ManagersFinance Vector Fund Management LP is a private company based in Deerfield, IL. | Corporate Officer/Principal | 01/01/1999 | 01/08/2008 |
| CancerVax Corp. | Directeur/Membre du Conseil | 01/12/2000 | 09/05/2006 |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ | - | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formation de Barclay Phillips
| University of Colorado Boulder | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 16 |
| Allemagne | 2 |
Opérationnelle
| Corporate Officer/Principal | 6 |
| Director/Board Member | 4 |
| Director of Finance/CFO | 4 |
Sectorielle
| Finance | 8 |
| Health Technology | 8 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| ACORDA THERAPEUTICS, INC. | Health Technology |
| NOVAVAX, INC. | Health Technology |
| G1 THERAPEUTICS, INC. | Health Technology |
| IMMUNIC, INC. | Health Technology |
| Entreprise privées | 11 |
|---|---|
Vector Asset Management, Inc.
Vector Asset Management, Inc. Investment ManagersFinance Vector Asset Management, Inc. is a venture capital firm based in Deerfield, Illinois | Finance |
| CancerVax Corp. | Commercial Services |
Invesco Advisers, Inc.
 Invesco Advisers, Inc. Investment ManagersFinance Invesco Advisers, Inc. is a SEC-registered investment advisor headquartered in Atlanta, Georgia. They are a subsidiary of Invesco Group Services, Inc., ultimately held by Invesco Ltd. (NYSE: IVZ). The firm was founded in 1986 and previously known as Invesco Institutional NA, Inc. until April 2010 when Invesco Ltd. consolidated the businesses of their US investment advisors (Invesco AIM Advisors, Inc., Invesco AIM Capital Management, Inc., Invesco AIM Private Asset Management, Inc. and Invesco Global Asset Management NA, Inc.) under the name Invesco Advisers, Inc. They provide discretionary and non-discretionary investment advisory services to individuals, institutional and high net-worth clients through separate accounts, wrap fee programs and US registered investment companies and other Commingled Funds. | Finance |
| PaineWebber, Inc. | Finance |
Amgen Rockville, Inc.
Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Health Technology |
Apjohn Ventures LLC
 Apjohn Ventures LLC Investment ManagersFinance Apjohn Ventures LLC (Apjohn Ventures) is a venture capital subsidiary of Apjohn Group LLC founded in 2002 by Mina Patel Sooch and Donald R Parfet. The firm is headquartered in Kalamazoo, Michigan. | Finance |
INVESCO Funds Group, Inc.
 INVESCO Funds Group, Inc. Investment ManagersFinance Part of Invesco Ltd., INVESCO Funds Group, Inc. is a company based in Denver, CO. | Finance |
| Shearson Lehman Hutton, Inc. | Finance |
Vector Fund Management LP
Vector Fund Management LP Investment ManagersFinance Vector Fund Management LP is a private company based in Deerfield, IL. | Finance |
Immunic AG
Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Health Technology |
Ribometrix, Inc.
Ribometrix, Inc. Pharmaceuticals: MajorHealth Technology Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC. | Health Technology |
- Bourse
- Insiders
- Barclay Phillips
- Expérience